Heart pumps: Abiomed gets FDA win for Impella CP

Mon, 09/10/2012 - 10:39am
Mass Device

Medical device company Abiomed touts 510(k) clearance for its "higher flow" Impella CP heart pump.

Abiomed logo

Abiomed (NSDQ:ABMD) is touting a regulatory win for its Impella CP heart pump.

The Danvers, Mass.-based medical device company said it landed 510(k) clearance from the FDA for the percutaneous, catheter-based heart pump, which it says can provide peak flows of 4 liters per minute, about 80% of what a healthy heart can pump.

The Impella CP is intended for "partial circulatory support using an extracorporeal bypass control unit, for periods up to 6 hours. It is also intended to be used to provide partial circulatory support (for periods up to 6 hours) during procedures not requiring cardiopulmonary bypass," according to a press release.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.